Related Experiment Video
Updated: Jan 17, 2026

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
Evaluating ECG Criteria for Diagnosing Left Ventricular Hypertrophy in Anabolic-Androgenic Steroid Users
Rang Abdullah1, Astrid Bjørnebekk2, Lisa E Hauger3
1University of Oslo, Oslo, Norway; ProCardio Center for Research Based Innovation, Department of Cardiology, Rikshospitalet, Oslo University Hospital, Oslo, Norway; Anabolic Androgenic Steroid Research Group, Section for Clinical Addiction Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Insights
Electrocardiography (ECG) is insufficient for detecting left ventricular hypertrophy (LVH) in anabolic-androgenic steroid (AAS) users. Echocardiography is recommended for early detection of LVH and associated cardiac dysfunction in this high-risk population.
Area of Science:
- Cardiology
- Sports Medicine
- Pharmacology
Background:
- Anabolic-androgenic steroid (AAS) users are a high-risk cardiovascular group.
- Left ventricular hypertrophy (LVH) is a common complication in AAS users.
- The effectiveness of electrocardiography (ECG) for detecting LVH in this population is unknown.
Purpose of the Study:
- To evaluate the diagnostic performance of six common ECG-LVH criteria.
- To identify LVH using echocardiography as the reference standard in long-term AAS users.
Main Methods:
- 100 male AAS users were studied (32 with echocardiographic LVH, 68 without).
- Six ECG-LVH criteria were assessed for sensitivity, specificity, and predictive values.
- Echocardiography was used as the gold standard; LV systolic function was evaluated via ejection fraction and global longitudinal strain.
Main Results:
- AAS users with LVH showed more significant LV systolic dysfunction (lower ejection fraction, impaired global longitudinal strain).
- Peguero-Lo Presti (sensitivity 31%, specificity 88%) and Romhilt-Estes (sensitivity 34%, specificity 85%) showed the best performance among ECG criteria.
- Most cases of echocardiographic LVH (66-69%) were missed by ECG criteria.
Conclusions:
- ECG is inadequate for detecting echocardiographic LVH in AAS users.
- Routine specialist evaluations, including echocardiography, are crucial for early detection of LVH and dysfunction in long-term AAS users.
Background:
Anabolic-androgenic steroid (AAS) users represent a high-risk cardiovascular population. Left ventricular (LV) hypertrophy (LVH) is a common complication, yet the utility of electrocardiographic (ECG) criteria for detecting LVH remains unexplored.
Objectives:
The objective of the study was to evaluate the diagnostic performance of six commonly used ECG-LVH criteria in identifying echocardiographic LVH among long-term AAS users.
Methods:
We included 100 male AAS users, 32 with echocardiographic LVH and 68 without. Six ECG-LVH criteria (Sokolow-Lyon, Modified Sokolow-Lyon, Cornell voltage, Cornell product, Peguero-Lo Presti, and Romhilt-Estes) were assessed for sensitivity, specificity, and predictive values, using echocardiography as the reference standard. LV systolic function was evaluated by LV ejection fraction and global longitudinal strain.
Results:
AAS users with echocardiographic LVH exhibited more pronounced LV systolic dysfunction than those without, as shown by a higher number of individuals with LV ejection fraction ≤40% (7 [23%] vs 4 [6%], P = 0.02) and more impaired LV global longitudinal strain (-14.7% ± 2.7% vs -16.5% ± 2.2%, P = 0.002). Among voltage-based indices, Peguero-Lo Presti provided the best balance between sensitivity (31%) and specificity (88%). The point-based Romhilt-Estes using a cutoff of 5 offered comparable performance, with a sensitivity of 34% and specificity of 85%. However, most AAS users with echocardiographic LVH were not identified by ECG, with 69% remaining undetected by Peguero-Lo-Presti and 66% by Romhilt-Estes.
Conclusions:
ECG was insufficient for identifying echocardiographic LVH in AAS users who represent a high-risk cardiovascular population. Routine specialist evaluations, including echocardiography, should be considered for long-term AAS users to facilitate early detection of LVH and associated dysfunctions.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Hypertension III: Clinical Manifestations and Diagnostic Studies

